Enviro Energy Capital Corp Com Npv (GEC) Börsenkurse

Upbeat Earnings News May Spark Early Rally On Wall Street

The major U.S. index futures are currently pointing to sharply higher on Wall Street on Wednesday, with stocks likely to see an early rally following the mixed performance seen in the previous...

ASML Rises 7% on Export Waiver; Intel Plans Layoffs, HSBC $3B Buyback Announced, and More

ASML Holding NV (NASDAQ:ASML) – Semiconductor stocks rose globally after news that the US will exempt chipmakers in Japan, the Netherlands, and South Korea from new export restrictions...

Futures Pointing To Another Lackluster Session On Wall Street

The major U.S. index futures are currently pointing to a roughly flat open on Tuesday, with stocks likely to extend the lackluster performance seen over the course of the previous session...

Form 8-K - Current report

Merck Announces Second-Quarter 2024 Financial Results

Total Worldwide Sales Were $16.1 Billion, an Increase of 7% From Second Quarter 2023; Excluding the Impact of Foreign Exchange, Growth Was 11% KEYTRUDA Sales Grew 16% to $7.3 Billion; Excluding...

U.S. Futures Climb Before Fed Meeting; Oil Prices Drop on China Demand Worries

U.S. index futures rose slightly in pre-market trading on Tuesday, with major corporate earnings and the start of the Federal Reserve’s policy meeting in focus. The Fed’s two-day...

F5 Shares Rise 15%; Diageo Falls 10% on Annual Sales Decline; BP Boosts Dividend and Buyback Program

F5 (NASDAQ:FFIV) – The security and networking solutions company reported adjusted earnings of $3.36 per share in the third fiscal quarter, beating LSEG’s estimate of $2.97 per share...

U.S. Stocks Finish Choppy Trading Session Little Changed

Stocks moved to the upside early in the session on Monday but showed a lack of direction over the course of the trading day. The major averages spent the day bouncing back and forth across the...

Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) as First-Line Treatment for Patients With Unresectable or Metastatic Urothelial Carcinoma

Opinion granted based on positive overall survival and progression-free survival results from the Phase 3 KEYNOTE-A39 trial Positive opinion marks step forward for a potential new first-line...

Merck Announces Fourth-Quarter 2024 Dividend

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the Board of Directors has declared a quarterly dividend of $0.77 per share of the company’s common...